Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction

Recently, hypoglycemic drugs belonging to sodium-glucose cotransporter 2 inhibitors (SGLT2i) have generated significant interest due to their clear cardiovascular benefits for heart failure with preserved ejection fraction (HFpEF) since there are no effective drugs that may improve clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Sai, He, Li-Li, Zhang, Guo-Rui, Zuo, Qing-Juan, Wang, Zhong-Li, Zhai, Jian-Long, Zhang, Ting-Ting, Wang, Yan, Ma, Hui-Juan, Guo, Yi-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276585/
https://www.ncbi.nlm.nih.gov/pubmed/35476142
http://dx.doi.org/10.1007/s00210-022-02243-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276585/
https://www.ncbi.nlm.nih.gov/pubmed/35476142
http://dx.doi.org/10.1007/s00210-022-02243-1

Ejemplares similares